Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.60 -0.01 (-0.12%)
As of 03:51 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.26 billion
P/E Ratio
13.16
Consensus Rating
Strong Buy
Volume
9,206 shares
Average Volume
84,214 shares
Today's Range
$4.59
$4.62
atai Life Sciences stock logo

2. atai Life Sciences NASDAQ:ATAI

$4.13 +0.17 (+4.29%)
Closing price 04:00 PM Eastern
Extended Trading
$4.13 0.00 (0.00%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life Sciences

Market Capitalization
$827.40 million
P/E Ratio
-4.54
Consensus Rating
Buy
Consensus Price Target
$11.25 (+172.4% Upside)
Volume
5.32 million shares
Average Volume
3.63 million shares
TuHURA Biosciences stock logo

3. TuHURA Biosciences NASDAQ:HURA

$3.25 +0.20 (+6.56%)
Closing price 04:00 PM Eastern
Extended Trading
$3.18 -0.06 (-2.00%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$141.96 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+289.7% Upside)
Volume
3.83 million shares
Average Volume
297,801 shares
Today's Range
$3.11
$3.90
zSpace stock logo

4. zSpace NASDAQ:ZSPC

$2.64 +0.35 (+15.28%)
As of 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$61.51 million
Consensus Rating
Buy
Consensus Price Target
$15.00 (+468.2% Upside)
Volume
228,821 shares
Average Volume
70,661 shares
Today's Range
$2.37
$2.99
OS Therapies stock logo

5. OS Therapies NYSE:OSTX

$1.78 +0.11 (+6.59%)
Closing price 04:00 PM Eastern
Extended Trading
$1.74 -0.04 (-2.53%)
As of 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$50.01 million
P/E Ratio
-2.07
Consensus Rating
Buy
Consensus Price Target
$18.00 (+911.2% Upside)
Volume
309,323 shares
Average Volume
732,022 shares
Ultrapar Participacoes stock logo

6. Ultrapar Participacoes NYSE:UGP

$3.20 +0.19 (+6.15%)
Closing price 03:59 PM Eastern
Extended Trading
$3.26 +0.06 (+2.03%)
As of 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ultrapar Participações SA, through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers, in addition to renewable electricity and compressed natural gas. More about Ultrapar Participacoes

Market Capitalization
$3.56 billion
P/E Ratio
8.88
Consensus Rating
Buy
Consensus Price Target
$3.20 (+0.2% Upside)
Volume
2.23 million shares
Average Volume
1.88 million shares
OnKure Therapeutics stock logo

7. OnKure Therapeutics NASDAQ:OKUR

$2.00 -0.03 (-1.48%)
Closing price 04:00 PM Eastern
Extended Trading
$2.19 +0.19 (+9.55%)
As of 05:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$27.02 million
P/E Ratio
-0.38
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,516.7% Upside)
Volume
56,289 shares
Average Volume
106,518 shares
Western Copper & Gold stock logo

8. Western Copper & Gold NYSE:WRN

$1.28 -0.01 (-0.78%)
As of 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$256.71 million
P/E Ratio
-64.00
Consensus Rating
Buy
Consensus Price Target
$4.00 (+212.5% Upside)
Volume
306,225 shares
Average Volume
361,881 shares
Quince Therapeutics stock logo

9. Quince Therapeutics NASDAQ:QNCX

$1.83 +0.23 (+14.38%)
Closing price 04:00 PM Eastern
Extended Trading
$1.87 +0.04 (+2.19%)
As of 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$98.13 million
P/E Ratio
-1.32
Consensus Rating
Buy
Consensus Price Target
$8.14 (+345.0% Upside)
Volume
757,011 shares
Average Volume
239,953 shares
Immunic stock logo

10. Immunic NASDAQ:IMUX

$0.85 +0.00 (+0.38%)
Closing price 04:00 PM Eastern
Extended Trading
$0.85 -0.01 (-0.61%)
As of 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$84.07 million
P/E Ratio
-0.69
Consensus Rating
Buy
Consensus Price Target
$7.50 (+780.1% Upside)
Volume
1.30 million shares
Average Volume
1.24 million shares
Reviva Pharmaceuticals stock logo

11. Reviva Pharmaceuticals NASDAQ:RVPH

$0.46 +0.01 (+2.79%)
Closing price 04:00 PM Eastern
Extended Trading
$0.47 +0.01 (+1.30%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$22.08 million
P/E Ratio
-0.58
Consensus Rating
Buy
Consensus Price Target
$9.00 (+1,856.5% Upside)
Volume
2.21 million shares
Average Volume
1.61 million shares
TriSalus Life Sciences stock logo

12. TriSalus Life Sciences NASDAQ:TLSI

$3.65 +0.08 (+2.24%)
Closing price 04:00 PM Eastern
Extended Trading
$3.65 0.00 (0.00%)
As of 04:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TriSalus Life Sciences, Inc, a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. More about TriSalus Life Sciences

Market Capitalization
$138.12 million
P/E Ratio
-3.26
Consensus Rating
Buy
Consensus Price Target
$10.75 (+194.5% Upside)
Volume
77,406 shares
Average Volume
60,805 shares
Denison Mine stock logo

13. Denison Mine NYSEAMERICAN:DNN

$2.16 +0.04 (+1.89%)
Closing price 04:10 PM Eastern
Extended Trading
$1.92 -0.25 (-11.34%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$1.94 billion
P/E Ratio
-36.00
Consensus Rating
Buy
Consensus Price Target
$3.00 (+38.9% Upside)
Volume
44.78 million shares
Average Volume
79.10 million shares
MannKind stock logo

14. MannKind NASDAQ:MNKD

$3.66 +0.24 (+7.02%)
Closing price 04:00 PM Eastern
Extended Trading
$3.63 -0.03 (-0.87%)
As of 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. More about MannKind

Market Capitalization
$1.12 billion
P/E Ratio
33.28
Consensus Rating
Buy
Consensus Price Target
$9.71 (+165.4% Upside)
Volume
4.56 million shares
Average Volume
2.38 million shares
Hochschild Mining stock logo

15. Hochschild Mining OTCMKTS:HCHDF

$4.08 0.00 (-0.05%)
As of 03:36 PM Eastern

Hochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. More about Hochschild Mining

Market Capitalization
$2.10 billion
Consensus Rating
Buy
Volume
13,809 shares
Average Volume
32,336 shares
Today's Range
$4.00
$4.14
50-Day Range
$3.20
$4.21
HIVE Digital Technologies stock logo

16. HIVE Digital Technologies NASDAQ:HIVE

$2.15 +0.03 (+1.42%)
Closing price 04:00 PM Eastern
Extended Trading
$2.14 -0.01 (-0.42%)
As of 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital Technologies

Market Capitalization
$492.65 million
P/E Ratio
-5.97
Consensus Rating
Buy
Consensus Price Target
$6.67 (+210.1% Upside)
Volume
6.30 million shares
Average Volume
14.55 million shares
Rezolve AI stock logo

17. Rezolve AI NASDAQ:RZLV

$3.14 +0.12 (+3.97%)
Closing price 04:00 PM Eastern
Extended Trading
$3.13 -0.01 (-0.45%)
As of 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$653.94 million
Consensus Rating
Buy
Consensus Price Target
$6.36 (+102.5% Upside)
Volume
6.67 million shares
Average Volume
6.81 million shares
Today's Range
$2.99
$3.15
Bitcoin Depot stock logo

18. Bitcoin Depot NASDAQ:BTM

$4.22 -0.60 (-12.45%)
Closing price 04:00 PM Eastern
Extended Trading
$4.22 0.00 (-0.12%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bitcoin Depot Inc owns and operates a network of cryptocurrency kiosks in North America. Its customers can buy and sell bitcoin, litecoin, and ethereum cryptocurrencies using the BTM kiosk network and other services. More about Bitcoin Depot

Market Capitalization
$271.39 million
P/E Ratio
-22.21
Consensus Rating
Buy
Consensus Price Target
$4.83 (+14.5% Upside)
Volume
2.63 million shares
Average Volume
996,193 shares
FibroBiologics stock logo

19. FibroBiologics NASDAQ:FBLG

$0.57 +0.02 (+3.62%)
Closing price 04:00 PM Eastern
Extended Trading
$0.57 +0.00 (+0.03%)
As of 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$24.08 million
P/E Ratio
-1.60
Consensus Rating
Buy
Consensus Price Target
$13.00 (+2,161.7% Upside)
Volume
262,146 shares
Average Volume
340,763 shares
Stardust Power stock logo

20. Stardust Power NASDAQ:SDST

$0.37 -0.03 (-7.28%)
Closing price 04:00 PM Eastern
Extended Trading
$0.39 +0.02 (+4.27%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$22.62 million
P/E Ratio
-0.50
Consensus Rating
Buy
Consensus Price Target
$5.11 (+1,274.0% Upside)
Volume
1.97 million shares
Average Volume
4.55 million shares
Genelux stock logo

21. Genelux NASDAQ:GNLX

$3.19 -0.09 (-2.74%)
Closing price 04:00 PM Eastern
Extended Trading
$3.21 +0.02 (+0.63%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. More about Genelux

Market Capitalization
$120.49 million
P/E Ratio
-3.71
Consensus Rating
Buy
Consensus Price Target
$17.75 (+456.4% Upside)
Volume
78,689 shares
Average Volume
185,007 shares
Akebia Therapeutics stock logo

22. Akebia Therapeutics NASDAQ:AKBA

$3.32 -0.03 (-0.90%)
Closing price 04:00 PM Eastern
Extended Trading
$3.32 0.00 (-0.15%)
As of 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Akebia Therapeutics, Inc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. More about Akebia Therapeutics

Market Capitalization
$880.27 million
P/E Ratio
-19.53
Consensus Rating
Buy
Consensus Price Target
$6.75 (+103.3% Upside)
Volume
3.06 million shares
Average Volume
4.18 million shares
Orchestra BioMed stock logo

23. Orchestra BioMed NASDAQ:OBIO

$2.72 +0.20 (+7.94%)
Closing price 04:00 PM Eastern
Extended Trading
$2.73 +0.01 (+0.37%)
As of 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Orchestra BioMed Holdings, Inc operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. More about Orchestra BioMed

Market Capitalization
$105.10 million
P/E Ratio
-1.53
Consensus Rating
Buy
Consensus Price Target
$14.00 (+414.7% Upside)
Volume
526,555 shares
Average Volume
296,087 shares
Mereo BioPharma Group stock logo

24. Mereo BioPharma Group NASDAQ:MREO

$1.66 +0.14 (+9.21%)
Closing price 04:00 PM Eastern
Extended Trading
$1.58 -0.08 (-4.52%)
As of 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$263.94 million
P/E Ratio
-23.71
Consensus Rating
Buy
Consensus Price Target
$7.20 (+333.7% Upside)
Volume
4.62 million shares
Average Volume
1.78 million shares
NRx Pharmaceuticals stock logo

25. NRx Pharmaceuticals NASDAQ:NRXP

$2.39 +0.07 (+3.02%)
Closing price 04:00 PM Eastern
Extended Trading
$2.44 +0.04 (+1.88%)
As of 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx Pharmaceuticals

Market Capitalization
$41.32 million
P/E Ratio
-1.19
Consensus Rating
Buy
Consensus Price Target
$28.50 (+1,092.5% Upside)
Volume
344,867 shares
Average Volume
502,666 shares